Not logged in Share Save
Share Save
Share Save
Share Save
First-line (1L) osimertinib (osi) ± platinum-pemetrexed chemotherapy (CTx) for EGFR-mutated (EGFRm) advanced non-small cell lung cancer (NSCLC): FLAURA2 Asian cohort Yang, J. C-H.; Kobayashi, K.; Chewaskulyong, B.; Tran, T. V.; Biswas, B.; Lee, K. H.; Feng, P-H.; Pham, X. D.; Yao, Y.; Kuyama, S.; Bing, J. Y. Tan Chun; Bhise, R.; Ahn, M-J.; Sriuranpong, V.; Li, R. K.; Monterroso, E. Armenteros; Barrett, K.; Albayaty, M.; Cheng, Y. Share Save
A randomized controlled trial to relieve distress of chemotherapy-induced peripheral neuropathy by magnetic field: SMILE study Kubo, E.; Satomi, E.; Mukohara, T.; Fuse, N.; Wakabayashi, M.; Tsukada, Y.; Ishiki, H.; Takayama, S.; Kanemitsu, Y.; Kishita, I.; Kobayashi, K.; Kurihara, C.; Hirano, N.; Ikeno, T.; Miura, T.; Sato, A. Share Save
Clinical significance of visual cardiac 18F-FDG uptake in advanced non-small cell lung cancer Hashimoto, Kosuke; Kaira, Kyoichi; Imai, Hisao; Yamaguchi, Ou; Mouri, Atsuto; Shiono, Ayako; Miura, Yu; Kobayashi, Kunihiko; Kagamu, Hiroshi; Kuji, Ichiei Share Save
Importance of subpleural fibrosis measured by a computer-aided system in patients with interstitial pneumonias, the prospective multicenter study Iwasawa, Tae; Okuda, Ryo; Johkoh, Takeshi; Sakai, Fumikazu; Fujimoto, Kiminori; Sumikawa, Hiromitsu; Egashira, Ryoko; Arai, Toru; Kondoh, Yasuhiro; Nakamura, Yutaro; Miyamoto, Atsushi; Tomii, Keisuke; Suda, Takafumi; Hebisawa, Akira; Handa, Tomohiro; Wasamoto, Satoshi; Inoue, Hiromasa; Narumoto, Osamu; Morita, Masato; Gon, Yasuhiro; Fujita, Masaki; Tasaka, Sadatomo; Takamatsu, Kazufumi; Ito, Hiroyuki; Baba, Tomohisa; Nukiwa, Toshihiro; Kobayashi, Kunihiko; Ogura, Takashi Share Save
Effect of telomere length and TERT/TERC rare variants on survival in Japanese patients with idiopathic interstitial pneumonias :Genetic predisposition study from the Japanese Idiopathic Interstitial Pneumonias (JIPS) Registry (NEJ036A) Hisata, Shu; Tanino, Yoshinori; Okuda, Ryo; Ogura, Takashi; Isshiki, Takuma; Horimasu, Yasushi; Hamada, Naoki; Arai, Naoki; Tsubata, Yukari; Suda, Takafumi; Horio, Yukihiro; Ishikawa, Nobuhisa; Kondoh, Yasuhiro; Toyoshima, Mikio; Ishii, Haruyuki; Abe, Mitsuhiro; Kato, Motoyasu; Tanigawa, Motoaki; Tomioka, Hiromi; Chiba, Hirofumi; Arai, Toru; Nishioka, Yasuhiko; Hattori, Noboru; Hoshino, Tomoaki; Shimizu, Yasuo; Sakamoto, Koji; Ishikawa, Shizukiyo; Mieno, Makiko Naka; Baba, Tomohisa; Miyazaki, Yasunari; Nukiwa, Toshihiro; Kobayashi, Kunihiko; Suzuki, Takuji; Hagiwara, Koichi Share Save
Impact of Cachexia and First-Line Systemic Therapy for Previously Untreated Advanced Non-Small Cell Lung Cancer: NEJ050A Miura, Keita; Shukuya, Takehito; Furuya, Naoki; Morita, Ryo; Kisohara, Akira; Mouri, Atsuto; Watanabe, Satoshi; Tanaka, Hisashi; Hirata, Aya; Hakozaki, Taiki; Hamai, Kosuke; Matsumoto, Naoko; Watanabe, Kana; Ashinuma, Hironori; Miyauchi, Eisaku; Sugano, Koji; Hosokawa, Shinobu; Amano, Koji; Morita, Satoshi; Kobayashi, Kunihiko; Maemonodo, Makoto; Takahashi, Kazuhisa Share Save
A phase II study of daily carboplatin plus irradiation followed by durvalumab therapy for older adults (≥75 years) with unresectable III non-small-cell lung cancer and performance status of 2: NEJ039A Mouri, A.; Kisohara, A.; Morita, R.; Ko, R.; Nakagawa, T.; Makiguchi, T.; Isobe, K.; Ishikawa, N.; Kondo, T.; Akiyama, M.; Bessho, A.; Honda, R.; Yoshimura, K.; Kagamu, H.; Kato, S.; Kobayashi, K.; Kaira, K.; Maemondo, M. Share Save
Lung immune prognostic index (LIPI) as a guide for addition of chemotherapy in immunotherapy in elderly patients (Pts) with non-small cell lung cancer (NSCLC): NEJ057 Honjo, O.; Tozuka, T.; Tsukita, Y.; Kushiro, K.; Hosokawa, S.; Uematsu, M.; Sumi, T.; Naito, T.; Ito, K.; Wakui, H.; Obata, H.; Inoue, T.; Kamimura, M.; Tsubata, Y.; Jingu, D.; Sato, M.; Miyauchi, E.; Morita, S.; Kobayashi, K.; Asahina, H. Share Save
FLAURA2: exploratory analysis of baseline (BL) and on-treatment plasma EGFRm dynamics in patients (pts) with EGFRm advanced NSCLC treated with first-line (1L) osimertinib (osi) ± platinum-pemetrexed Janne, Pasi A.; Kobayashi, Kunihiko; Robichaux, Jacqulyne; Lee, Chee Khoon; Sugawara, Shunichi; Yang, Tsung-Ying; Kim, Tae Min; Yanagitani, Noriko; Kim, Sang-We; Markovets, Aleksandra; Bhetariya, Preetida; Poole, Lynne; Ghiorghiu, Dana; Hartmaier, Ryan; Yang, James Chih-Hsin; Planchard, David Share Save
Immunotherapy With Radiotherapy for Brain Metastases in Patients With NSCLC: NEJ060 Tozuka, Takehiro; Minegishi, Yuji; Yamaguchi, Ou; Watanabe, Kana; Toi, Yukihiro; Saito, Ryota; Nagai, Yoshiaki; Tamura, Yosuke; Shoji, Tetsuaki; Odagiri, Haruka; Ebi, Noriyuki; Sakai, Kosuke; Kanaji, Nobuhiro; Izumi, Makoto; Soda, Sayo; Watanabe, Satoshi; Morita, Satoshi; Kobayashi, Kunihiko; Seike, Mashiro Share Save
A phase II study of atezolizumab with bevacizumab, carboplatin, and paclitaxel for patients with EGFR-mutated NSCLC after TKI treatment failure (NEJ043 study) Watanabe, Satoshi; Furuya, Naoki; Nakamura, Atsushi; Shiihara, Jun; Nakachi, Ichiro; Tanaka, Hisashi; Nakao, Mika; Minato, Koichi; Seike, Masahiro; Sasaki, Shinichi; Kisohara, Akira; Takeuchi, Susumu; Honda, Ryoichi; Takamura, Kei; Kagamu, Hiroshi; Yoshimura, Kenichi; Kobayashi, Kunihiko; Kikuchi, Toshiaki Share Save
Osimertinib with or without Chemotherapy in EGFR-Mutated Advanced NSCLC Planchard, D.; Janne, P. A.; Cheng, Y.; Yang, J. C. -H.; Yanagitani, N.; Kim, S-W; Sugawara, S.; Yu, Y.; Fan, Y.; Geater, S. L.; Laktionov, K.; Lee, C. K.; Valdiviezo, N.; Ahmed, S.; Maurel, J-M; Andrasina, I; Goldman, J.; Ghiorghiu, D.; Rukazenkov, Y.; Todd, A.; Kobayashi, K. Share Save
Efficacy of whole brain radiotherapy for patients with leptomeningeal metastasis of non-small cell lung cancer: NEJ049 Furuta, Megumi; Miyauchi, Eisaku; Suzuki, Aya; Ashinuma, Hironori; Arai, Daisuke; Shimonishi, Atushi; Hosokawa, Shinobu; Hotta, Takamasa; Inomata, Minehiko; Morita, Satoshi; Ko, Ryo; Okuma, Yusuke; Sasaki, Takaaki; Kaira, Kyoichi; Kobayashi, Kunihiko; Sugiura, Hisatoshi Share Save
First-line (1L) osimertinib plus platinum-pemetrexed in EGFRmutated (EGFRm) advanced NSCLC: Updated FLAURA2 safety run-in (SRI) results Planchard, D.; Poltoratskiy, A.; Kim, S-W.; Kim, T. M.; Yanagitani, N.; Kagamu, H.; Feng, P-H.; Hughes, B.; Yang, T-Y.; Yang, J. C-H.; Lee, C. K.; Karaseva, N.; Mitchell, P.; Tambo, Y.; Monterroso, E. Armenteros; Todd, A.; Sahasrabudhe, A.; Janne, P. A.; Kobayashi, K. Share Save
Acquired mechanisms of resistance to first-line (1L) osimertinib with or without platinum-based chemotherapy (CT) in EGFR-mutated (EGFRm) advanced NSCLC: Preliminary data from FLAURA2 Lee, C. K.; Robichaux, J. P.; Janne, P. A.; Kim, S-W.; Kim, T. M.; Kobayashi, K.; Planchard, D.; Sugawara, S.; Yanagitani, N.; Yang, T-Y.; Markovets, A.; Bhetaryia, P.; Poole, L.; Rukazenkov, Y.; Hartmaier, R. J.; Yang, J. C-H. Share Save
A phase II study of daily carboplatin plus irradiation followed by durvalumab for unresectable III non-small cell lung cancer patients with PS 2 or elderly (S75 years): NEJ039A Ko, R.; Mouri, A.; Kisohara, A.; Morita, R.; Nakagawa, T.; Makiguchi, T.; Isobe, K.; Ishikawa, N.; Kondo, T.; Akiyama, M.; Bessho, A.; Honda, R.; Yoshimura, K.; Kagamu, H.; Kato, S.; Kobayashi, K.; Kaira, K. Share Save
.png){kind=icon}
.png){kind=icon}
Not logged in.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
